Literature DB >> 8385265

Alternatively spliced T cell receptor transcripts expressed in human T lymphocytes.

S Roman-Roman1, L Ferradini, O Azogui, F Faure, T Hercend, F Triebel.   

Abstract

We used the anchored-polymerase chain reaction (A-PCR) procedure to study human TCR transcripts derived from a variety of polyclonal T cell populations. In this series of experiments, 31 'unusual' cDNAs, which do not include exclusively V-J-C, J-C or 5'C genomic sequences, were identified. Ten of these were found to represent distinct types of alternatively spliced TCR alpha transcripts whose structure is derived from unusual splicing of one, two or even three intervening intronic sequences. The splicing events led to either conservation of a novel exon in the mRNA structure (designated aE1 alpha-aE5 alpha) between the V-J and C segments or to deletion of the 3' V region-J segment. In three cases, the alternatively spliced exons (aE1 alpha-aE3 alpha) interrupt the open translational reading frame of the corresponding V-J alpha segment. Nineteen and two cDNA represent sterile C beta or C delta transcripts, respectively. Their structures are derived from the conservation of a non-translatable exon, aE1 beta or aE1 delta, which is precisely spliced at the 5' end of the corresponding C exon sequences. Interestingly, the 3' region of the aE1 beta sequence is homologous to the murine C beta 0 exon. Together, these results led to the characterization of nine novel exons in the TCR alpha, beta and delta loci.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385265     DOI: 10.1016/0161-5890(93)90110-w

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  1 in total

1.  TRIg: a robust alignment pipeline for non-regular T-cell receptor and immunoglobulin sequences.

Authors:  Sheng-Jou Hung; Yi-Lin Chen; Chia-Hung Chu; Chuan-Chun Lee; Wan-Li Chen; Ya-Lan Lin; Ming-Ching Lin; Chung-Liang Ho; Tsunglin Liu
Journal:  BMC Bioinformatics       Date:  2016-10-26       Impact factor: 3.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.